Jeffrey Stoll News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jeffrey stoll. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jeffrey Stoll Today - Breaking & Trending Today
ALLENDALE TWP., MI (WHTC-AM/FM, Oct. 23, 2022) - For the third time in this fall semester, there has been a reported shooting at an off-campus apartme. ....
Life Sciences Deal-Making Gets Creative, Aims At Early Stages Amid COVID-19 By Jeff Stoll and Kristin Pothier Life sciences companies remain unabated when it comes to creatively making deals during the COVID-19 pandemic, particularly among those targeting biopharma companies with early-stage assets. In the KPMG 2021 Healthcare & Life Sciences Investment Outlook, we tallied 1,138 acquisitions, licensing, and R&D deals announced in 2020, an increase from 634 in 2019. In 2020, we saw 121 company acquisitions globally versus 79 in 2019. The dollar value of the deals was smaller than in 2019, but the volume of deals shows that investors don’t want to miss early-stage opportunities. Our survey of life sciences executives and investors found that 71% were interested in targeting early-stage assets, compared with 39% who favored late-stage assets with greater certainty of near-term revenue. Only 29% were interested in significantly sized acquisitions/mergers and ....
Winter is already here, but for much of Michigan, it seems like there has not been as much winter weather as we might expect. Although there has not been a huge amount of snowfall, the Grand Valley Police Department is urging the Grand Valley State University community to take precautions for when there is snow and ice on the roads. “Plan ahead, check the weather, be understanding that conditions can change rather quickly, and even if you do plan ahead, there may be a time where you think you’re going to make it on time, and you might end up being a little bit late,” said GVPD Capt. Jeffrey Stoll. “But it’s always going to be more beneficial to be patient and be safe than it is to rush.” ....
3 Strategies To Address The Biggest Concerns Facing Generic Drug Makers By Roger van den Heuvel, Mary Rollman, and Jeff Stoll, KPMG Generic drugs, which account for 90% of the prescriptions filled in the U.S., have been a constraint on pharmaceutical inflation for decades, with many payers touting their “drug trend” a measure of spending growth of pharmaceutical drugs. Generic drug sales have grown 5.7% annually, from 2014 to 2019, and additional patent expirations could sustain 5.4% generic drug growth to $497 billion by 2025. Amid this opportunity for generic drug makers to capitalize on patent expiration, they’re facing struggles around pricing power. COVID-19 also exposed the fragility of supply chains that were built with economic efficiency rather than resiliency in mind. ....